Noble Wealth Management PBC’s Bristol-Myers Squibb BMY Stock Holding History

Noble Wealth Management PBC’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$922	Buy	+16	New	+$919	﹤0.01%	722

Other funds holding BMY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Noble Wealth Management PBC's BMY Position: Q2 2026 in Review

Noble Wealth Management PBC opened a new position in Bristol-Myers Squibb (BMY) in Q2 2026: 16 shares worth $922. The stake represents ﹤0.01% of the portfolio and ranks #722 among its holdings.

954 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Noble Wealth Management PBC held 16 shares of Bristol-Myers Squibb worth $922 as of Q2 2026.
Bristol-Myers Squibb was a new Noble Wealth Management PBC position in Q2 2026.
Bristol-Myers Squibb made up ﹤0.01% of Noble Wealth Management PBC's portfolio in Q2 2026, its #722 holding.
954 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Noble Wealth Management PBC's 13F filing for Q2 2026, filed 1 Jul 2026.